Programs

Sources & references.

Every regulatory and clinical statement on this site traces to an official source. Below, each is linked to the U.S. Food & Drug Administration, the Drug Enforcement Administration, the National Institutes of Health, or the peer-reviewed study it comes from.

Compounded medications & the FDA

Compounded medications are prepared for an individual patient by a state-licensed compounding pharmacy pursuant to a prescription. They are not FDA-approved finished drug products, and the FDA does not review compounded medications for safety, effectiveness, or quality.

FDA — Compounding and the FDA: Questions and Answers ↗

Pharmaceutical compounding is governed by enforceable United States Pharmacopeia (USP) standards: General Chapter <795> for nonsterile preparations and General Chapter <797> for sterile preparations, which set requirements for personnel, facilities, components, and quality assurance. These are the "real standard" a compounding pharmacy compounds to.

USP General Chapter <795> — Pharmaceutical Compounding, Nonsterile Preparations ↗  ·  USP General Chapter <797> — Sterile Preparations ↗

Refrigerated injectable medications such as semaglutide are stored at 2°C to 8°C (36°F to 46°F), protected from light, and not frozen, per FDA-approved product labeling.

NIH DailyMed — WEGOVY (semaglutide) FDA label: Storage and Handling ↗

Compounded semaglutide & tirzepatide (GLP-1)

Compounded semaglutide and tirzepatide are not FDA-approved and are not generic equivalents of, or interchangeable with, the brand-name products (Ozempic, Wegovy, Mounjaro, Zepbound), which are the only FDA-approved semaglutide and tirzepatide medicines.

FDA — Concerns with unapproved GLP-1 drugs used for weight loss ↗

GLP-1 medicines in the semaglutide class are contraindicated in patients with a personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2). Acute pancreatitis has been observed with GLP-1 receptor agonists, and the medicine should be discontinued in patients who become pregnant while using it for weight reduction. A licensed provider screens for these and other factors during intake.

NIH DailyMed — WEGOVY (semaglutide) FDA label: Contraindications & Warnings ↗

The most common adverse reactions reported with semaglutide are gastrointestinal, including nausea, diarrhea, vomiting, and constipation.

NIH DailyMed — WEGOVY (semaglutide) FDA label: Adverse Reactions ↗

Wellness injectables (NAD+, glutathione, B12 / MIC)

NAD+, glutathione, and MIC injectables are compounded preparations and are not FDA-approved to prevent, treat, or cure any disease (see FDA compounding above).

FDA — Compounding and the FDA: Questions and Answers ↗

Vitamin B12 is built around a single cobalt atom (hence "cobalamin"), functions as a cofactor for two enzymes (methionine synthase and L-methylmalonyl-CoA mutase), and is required for the development, myelination, and function of the central nervous system, healthy red blood cell formation, and DNA synthesis.

NIH Office of Dietary Supplements — Vitamin B12 fact sheet ↗

Through its cofactor enzymes, vitamin B12 participates in the metabolism of fatty acids and amino acids: L-methylmalonyl-CoA mutase converts L-methylmalonyl-CoA to succinyl-CoA in the metabolism of a short-chain fatty acid, and methionine synthase supports methionine (amino acid) metabolism, feeding the pathways cells use to turn food into usable energy.

NIH Office of Dietary Supplements — Vitamin B12 fact sheet ↗

Choline is a source of methyl groups needed for many steps in metabolism and is essential (especially as phosphatidylcholine) for transporting lipids out of the liver; in choline deficiency, fat accumulates in the liver, which can result in non-alcoholic fatty liver disease (NAFLD). The U.S. formally recognized choline as an essential nutrient in 1998.

NIH Office of Dietary Supplements — Choline fact sheet ↗

Choline is needed to produce acetylcholine, a neurotransmitter involved in memory, mood, and muscle control.

NIH Office of Dietary Supplements — Choline fact sheet ↗

The Institute of Medicine formally recognized choline as an essential nutrient in the U.S. in 1998.

Dietary choline intake across the life cycle — PMC6213596 ↗

Methionine is an essential amino acid the body cannot synthesize; it is the precursor to S-adenosylmethionine (SAMe), a universal methyl donor for methylation reactions throughout the body.

Methionine cycle & SAMe as a universal methyl donor — PMC8775811 ↗

Methionine is metabolized largely in the liver to SAMe and, through the transsulfuration pathway, contributes to the synthesis of glutathione.

S-adenosylmethionine metabolism & liver disease — PMC4027041 ↗

Inositol is incorporated into cell membranes and is a precursor to second messengers (such as IP3) used in cell signaling; it acts as a mediator in insulin signaling and is a lipotropic compound involved in lipid (fat) metabolism.

Inositols and metabolic disorders (review) — PMC7340869 ↗

Clinical-trial figures cited on this site

Trial results referenced on the product pages come from studies of the branded, FDA-approved medicines. Compounded versions share the active ingredient but are not the identical product and have not been individually studied.

Semaglutide weight-loss results (STEP 1 trial).

STEP 1 — PMC9542252 (National Library of Medicine) ↗

Semaglutide cardiovascular-event reduction in obesity without diabetes (SELECT trial).

SELECT — PMC11439431 ↗

Tirzepatide is a dual GIP / GLP-1 receptor agonist: it binds the GIP receptor with affinity comparable to native GIP, while its GLP-1-receptor affinity is roughly 18–20× weaker than native GLP-1; its gastric-slowing ("feel full longer") effect is driven by GLP-1-receptor agonism, not GIP.

Mechanism review — PMC12847476 ↗

In SURMOUNT-1, tirzepatide's weight loss was approximately 74% fat mass / 26% lean mass (versus 75% / 25% on placebo), preserving the fat-to-lean loss ratio.

SURMOUNT-1 body-composition substudy — PMC11965027 ↗

GLP-1 receptor agonists such as semaglutide work with the body's appetite signals: enhancing satiety, slowing gastric emptying, and reducing hunger and energy intake.

GLP-1 analogues, appetite & gastric emptying — systematic review, PMC9987242 ↗

Patients on GLP-1 medications frequently report a reduction in "food noise," persistent, intrusive thoughts about food; this patient-reported effect is beginning to be documented in early research.

"Food noise" / food-cue reactivity — PMC10674813 ↗

Glutathione is often called the body's "master antioxidant" and is the most abundant thiol antioxidant in human cells.

Glutathione as the "master antioxidant" — PMC9616098 ↗

Glutathione is a tripeptide the body builds from three amino acids: glutamate (glutamic acid), cysteine, and glycine.

Wu et al., "Glutathione Metabolism and Its Implications for Health," J. Nutrition (2004) ↗

Glutathione helps regenerate other antioxidants, recycling oxidized vitamin C back to its active form, which in turn helps restore vitamin E.

Glutathione & the antioxidant network (vitamin C/E regeneration) — PMC7690269 ↗

Glutathione's antioxidant activity helps protect skin cells against UV-induced oxidative damage.

Schäfer et al., glutathione-mediated UVB cytoprotection in the epidermis — PMC2867209 ↗

Glutathione is central to the liver's phase II detoxification, where it conjugates toxins and drug byproducts to make them water-soluble for excretion.

Pizzorno, "Glutathione!," Integrative Medicine (2014) — PMC4684116 ↗

Glutathione plays an important role in normal immune function, including cytokine production and immune-cell activity.

Wu et al., J. Nutrition (2004) ↗

Glutathione participates in melanin biochemistry, influencing the balance between eumelanin and pheomelanin pigment.

Thioredoxin & glutathione systems in melanogenesis — PMC8112849 ↗

As a primary cellular antioxidant, glutathione neutralizes free radicals and helps protect DNA and other cell components from the oxidative damage that harms lipids, proteins, and DNA.

Pizzorno, "Glutathione!," Integrative Medicine (2014) — PMC4684116 ↗

Glutathione levels tend to decline with age, and glutathione deficiency contributes to the oxidative stress associated with aging.

Chin et al., glutathione across the age span (systematic review) — PMC10520675 ↗

Roughly 85% of cellular NAD+ is regenerated through the salvage pathway.

NAD+ salvage pathway — PMC11450036 ↗

Cellular NAD+ levels decline with age, and this decline is associated with mitochondrial dysfunction and reduced cellular energy metabolism.

NAD+ metabolism in mitochondrial & age-related disorders — PMC4963347 ↗

About this page. The facts behind every statement on this site come from the official sources linked above. The wording on our pages is our own; nothing is copied from another company. This page is provided for transparency and is not a substitute for the full prescribing information or for medical advice. Availability and regulatory status of compounded medications can change; a licensed provider makes all prescribing decisions.